AdventHealth Sebring

Recent papers from AdventHealth Sebring

1. Tau A152T risk variant drives distinct cell type transcriptional signatures in AD and PSPActa Neuropathologica · 2026
2. Rural-Urban Disparities in Heart Failure and Liver Cirrhosis Hospitalizations: A National Inpatient Sample Database Analysis (2016–2022)International Journal of Heart Failure · 2026
3. Giant Cell Arteritis: Cardiac and Aortic Complications at the Cardio-Rheumatology InterfaceJournal of Vascular Diseases · 2026
4. Clinical Outcomes of Sodium Glucose Cotransporter‐2 Inhibitors in Patients Undergoing Mitral Transcatheter Edge‐to‐Edge RepairCatheterization and Cardiovascular Interventions · 2026
5. Trends and regional variations of ischemic heart disease and liver cirrhosis-related mortality among American adults (1999-2023)Clinical Epidemiology and Global Health · 2026
6. Fasinumab for osteoarthritis: a systematic review and meta-analysis of efficacy and safetyBMC Musculoskeletal Disorders · 2026
7. Cancer prevalence in the United States: trends and sociodemographic disparities based on national health interview survey data (2019–2023)Frontiers in Oncology · 2026
8. Association of the Neutrophil Percentage-to-Albumin Ratio with All-Cause Mortality in Patients with Heart Failure: A Systematic Review and Meta-AnalysisCardiology in Review · 2026
9. Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney FailureJAMA · 2026
10. Efficacy of Metformin in Prevention of Glucocorticoid‐Induced Hyperglycemia in Patients Without Diabetes: A Meta‐AnalysisEndocrinology Diabetes & Metabolism · 2026
11. Critical shortage of gastrointestinal physician density in the USA: impact on mortality from upper gastrointestinal bleedingFrontiers in Medicine · 2026
12. Externally Validated Machine Learning Models for 30-/90-/180-Day Unplanned Readmission After Head and Neck Cancer Hospitalizations in the United StatesJCO Clinical Cancer Informatics · 2026
13. Real-world incidence, prevalence, and short-term outcomes in young-onset breast cancer.Journal of Clinical Oncology · 2026
14. Bispecific antibodies in breast cancer: A systematic landscape analysis of clinical trials.Journal of Clinical Oncology · 2026
15. Nationwide trends, hospital volume, and drivers of survey-weighted 30-day unplanned readmission after pancreatic resection (NRD 2016–2022).Journal of Clinical Oncology · 2026
16. Shifting etiologic burden of hepatocellular carcinoma hospitalizations in the United States, 2016–2022: A National Inpatient Sample analysis.Journal of Clinical Oncology · 2026
17. Efficacy and safety of transarterial chemoembolization (TACE) plus sorafenib vs TACE alone in the treatment of non-resectable hepatocellular carcinoma: A systematic review and meta-analysis.Journal of Clinical Oncology · 2026
18. Definitive non-surgical management of locally advanced esophageal adenocarcinoma: A systematic review and meta-analysis.Journal of Clinical Oncology · 2026
19. Real-world cardiotoxicity with HER2 antibody–drug conjugates and survival after treatment continuation.Journal of Clinical Oncology · 2026
20. GLP-1 therapy and hormone receptor–positive breast cancer risk and survival: A real-world analysis.Journal of Clinical Oncology · 2026